Please assess the completion status of the following clinical trial:

Trial Title: Effects of Vitamin D on Renin Expression in Hypertensive Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Male or female patients age \> 55 years.~2. Female patients must be postmenopausal, as determined by surgical hysterectomy or 12 month history since last active menstruation~3. Stage I hypertension (JNC VII Criteria): mean systolic blood pressure (mSBP) 140-159 mmHg and mean diastolic blood pressure 90 - 99 mmHg (mDBP)2~4. Provide informed consent~Exclusion Criteria:~1. Serum vitamin D \<55 pmol/L~2. Serum calcium \>10.5 mg/dL~3. Serum phosphate (inorganic) \>5.5 mg/dL~4. Serum parathyroid hormone (PTH) \>1.3 pmol/L~5. Vitamin D supplements, calcium supplements, estrogen replacement therapy, corticosteroids (inhaled/oral), or hydroxymethyl glutarate CoA reductase inhibitors (statins) within 30 days prior to randomization~6. Stage II hypertension (JNC VII criteria): mSSBP \>160 mmHg or mSDBP \>100 mmHg~7. Use of alpha2-agonists, beta-blockers, or more than 2 anti-hypertensive medications at screening~8. Estimated creatinine clearance \<30 mL/min by Crockroft-Gault Formula~9. History of heart failure (HF), acute myocardial infarction (AMI), acute coronary syndrome (ACS), transient ischemic attack (TIA), cerebrovascular accident (CVA), peripheral vascular disease (PVD), or known clotting disorder~10. Insulin dependent diabetes mellitus (patients stabilized on oral regimens may be enrolled)~11. History of hypersensitivity reaction to 1α, 25-(OH)2 vitamin D3 (calcitriol)

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Calcitriol (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).